- Home
- ICLR vs BCH Comparison
ICLR vs BCH Comparison
Compare ICLR & BCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- BCH
- Stock Information
- Founded
- ICLR 1990
- BCH 1893
- Country
- ICLR Ireland
- BCH Chile
- Employees
- ICLR N/A
- BCH N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- BCH Commercial Banks
- Sector
- ICLR Health Care
- BCH Finance
- Exchange
- ICLR Nasdaq
- BCH Nasdaq
- Market Cap
- ICLR 11.5B
- BCH 13.1B
- IPO Year
- ICLR 1998
- BCH 2002
- Fundamental
- Price
- ICLR $133.96
- BCH $30.48
- Analyst Decision
- ICLR Buy
- BCH Hold
- Analyst Count
- ICLR 12
- BCH 1
- Target Price
- ICLR $206.64
- BCH $23.00
- AVG Volume (30 Days)
- ICLR 2.1M
- BCH 282.3K
- Earning Date
- ICLR 04-30-2025
- BCH 04-29-2025
- Dividend Yield
- ICLR N/A
- BCH 6.89%
- EPS Growth
- ICLR 11.53
- BCH N/A
- EPS
- ICLR 9.19
- BCH 0.01
- Revenue
- ICLR $8,192,621,999.00
- BCH $2,816,160,332.00
- Revenue This Year
- ICLR $1.63
- BCH $18.69
- Revenue Next Year
- ICLR $4.82
- BCH $5.24
- P/E Ratio
- ICLR $15.07
- BCH $11.82
- Revenue Growth
- ICLR N/A
- BCH N/A
- 52 Week Low
- ICLR $133.28
- BCH $22.06
- 52 Week High
- ICLR $347.72
- BCH $30.83
- Technical
- Relative Strength Index (RSI)
- ICLR 33.96
- BCH 64.96
- Support Level
- ICLR $135.00
- BCH $29.12
- Resistance Level
- ICLR $141.96
- BCH $30.95
- Average True Range (ATR)
- ICLR 6.69
- BCH 0.70
- MACD
- ICLR 0.43
- BCH 0.05
- Stochastic Oscillator
- ICLR 3.63
- BCH 78.93
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About BCH Banco De Chile ADS
Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile) Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.